HUNTINGTON'S DISEASE (HD)
Clinical trials for HUNTINGTON'S DISEASE (HD) explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON'S DISEASE (HD) trials appear
Sign up with your email to follow new studies for HUNTINGTON'S DISEASE (HD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Huntington's: drug aims to lower toxic proteins
Disease control ENROLLING_BY_INVITATIONThis study tests an oral drug called SKY-0515 in 500 adults with Huntington's disease who have already taken it before. The goal is to see if the drug can safely lower harmful proteins and improve symptoms over the long term. Participants must be 25 or older and have a genetic co…
Matched conditions: HUNTINGTON'S DISEASE (HD)
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New brain scans aim to catch Huntington's cognitive decline earlier
Knowledge-focused OngoingThis study aims to create new, more sensitive cognitive tests for Huntington's disease by combining brain imaging (PET and MRI) with blood markers. Researchers will study 90 people—30 healthy controls, 30 gene carriers without symptoms, and 30 early-stage patients—to better under…
Matched conditions: HUNTINGTON'S DISEASE (HD)
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC